Q/C Technologies, Inc. (QCLS): EPS (Basic)
-$8.66
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.66 | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$1080.87 | n/c | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$5.33 | n/m | 2025-04-11, From 2023-01-01 |
| 2022-12-31 | -$11.74 | n/c | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$0.85 | n/a | 2023-03-31, From 2021-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Q/C Technologies, Inc. (QCLS) | 2025-12-31 | -$8.66 | n/m |
| Achieve Life Sciences, Inc. (ACHV) | 2025-12-31 | -$1.25 | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | -$0.12 | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $0.15 | +162.5% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$1.65 | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$0.32 | n/m |
| Cardio Diagnostics Holdings, Inc. (CDIO) | 2025-12-31 | -$3.71 | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | -$1.30 | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$0.37 | n/m |
Compare QCLS, ACHV, ICCC, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗